I now have comprehensive information. Here is a complete answer:
Letrozole for Ovulation Induction — Dosing
Starting Dose
2.5 mg/day orally, typically on cycle days 3–7 (or days 5–9), for 5 days.
Dose Escalation
If ovulation does not occur, the dose is increased by 2.5 mg increments in each subsequent cycle:
- 2.5 mg → 5 mg → 7.5 mg → up to a maximum of 7.5 mg/day in most protocols
Maximum Dose
| Context | Maximum |
|---|
| Clinically used / evidence-based | 7.5 mg/day (most commonly cited ceiling in practice) |
| As referenced in trials | Starting dose in landmark PCOS trial was 2.5 mg; doses up to 7.5 mg are standard |
The textbook notes this context specifically for clomiphene, where the FDA-approved maximum is 100 mg/day. For letrozole (an off-label use), the dosing escalation goes up to 7.5 mg/day as the typical maximum in clinical practice, with doses up to higher levels occasionally described in resistant cases.
Important note from Berek & Novak's Gynecology: Letrozole use for ovulation induction is off-label (pregnancy category X). Dosing starts at 2.5 mg and is increased by 2.5 mg each non-responsive cycle.
Stair-Step Protocol (Alternative)
Instead of waiting for the next cycle, if no follicular response is seen on ultrasound 4–5 days after the last dose, the dose is increased within the same cycle — avoiding an intervening menses.
Treatment Duration Limit
Ovulation induction should be limited to 6 ovulatory cycles or 12 total cycles.
Why Letrozole?
- Higher cumulative live birth rates vs. clomiphene in PCOS (27.5% vs. 19.1%; RR 1.44)
- Lower twin pregnancy rates (3.4% vs. 7.4%)
- Preferred first-line agent in anovulatory PCOS, particularly in obese women (BMI >30)
- Shorter half-life (48 hours) vs. clomiphene (2 weeks) → less anti-estrogenic endometrial effect
— Berek & Novak's Gynecology, "Ovulation Induction Dosing" section